View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorized
March 19, 2012

UK Government invests in pharmaceutical packaging to reduce vaccine wastages

The UK Government is investing in a wool packaging solution for pharmaceuticals to reduce vaccine wastages of more than 50% as reported by the World Health Organisation.

Wool Packaging solutionThe UK Government is investing in a wool packaging solution for pharmaceuticals to reduce vaccine wastages of more than 50% as reported by the World Health Organisation.

The Wool Packaging Company based in Shropshire, England, has received a grant from the Technology Strategy Board to develop specialised pharmaceuticals version of its Woolcool insulated packaging.

Woolcool insulated packaging was proven to maintain stable internal temperatures between 2°C and 8°C in excess of 72 hours and provides cushioning protection for fragile contents, the company said.

Wool is a naturally effective insulator and is abundantly available, hence the Woolcool packaging products are considered as sustainable solutions.

The insulated packaging solution was originally designed for the food sector to directly deliver fresh and frozen foods.

The Wool Packaging Company manufactures and supplies environmentally-friendly insulated packaging products and packaging solutions for all temperature sensitive goods, from food to pharmaceuticals.

The Technology Strategy Board is a business-led government body which works to create economic growth.

Sponsored by the Department for Business, Innovation and Skills (BIS), the Technology Strategy Board brings together business, research and the public sector, supporting and accelerating the development of new products and services to meet market needs.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU